|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Occult hepatitis B virus infection among Egyptian blood donors显示文摘AIM:To identify blood donors with occult hepatitis B virus(HBV) infection(OBI) to promote safe blood donation.METHODS:Descriptive cross sectional study was conducted on 3167 blood donors negative for hepatitis B surface antigen(HBsAg),hepatitis C antibody(HCV Ab) and human immunodeficiency virus Ab.They were subjected to the detection of alanine aminotransferase(ALT) and aspartate transaminase(AST) and screening for anti-HBV core antibodies(total) by two different techniques;[Monoliza antibodies to hepatitis B core(Anti-HBc) Plus-Bio-Rad] and(ARC-HBc total-ABBOT).Positive samples were subjected to quantitative detection of antibodies to hepatitis B surface(anti-HBs)(ETI-AB-AUK-3,Dia Sorin-Italy).Serum anti-HBs titers > 10 IU/L was considered positive.Quantitative HBV DNA by real time polymerase chain reaction(PCR)(QIAGEN-Germany) with 3.8 IU/mL detection limit was estimated for blood units with negative serum anti-HBs and also for 32 whose anti-HBs serum titers were > 1000 IU/L.Also,265 recipients were included,34 of whom were followed up for 3-6 mo.Recipients were investigated for ALT and AST,HBV serological markers:HBsAg(ETI-MAK-4,Dia Sorin-Italy),anti-HBc,quantitative detection of anti-HBs and HBV-DNA.RESULTS:525/3167(16.6%) of blood units were positive for total anti-HBc,64% of those were antiHBs positive.Confirmation by ARCHITECT anti-HBc assay were carried out for 498/525 anti-HBc positive samples,where 451(90.6%) confirmed positive.Reactivity for anti-HBc was considered confirmed only if two positive results were obtained for each sample,giving an overall prevalence of 451/3167(14.2%) for total anti-HBc.HBV DNA was quantified by real time PCR in 52/303(17.2%) of anti-HBc positive blood donors(viral load range:5 to 3.5 x 105 IU/mL) with a median of 200 IU/mL(mean:1.8 x 104 ± 5.1 x 104 IU/mL).AntiHBc was the only marker in 68.6% of donors.Univariate and multivariate logistic analysis for identifying risk factors associated with anti-HBc and HBV-DNA positivity among blood donors showed that age above thirty and marriage were the most significant risk factors for prediction of anti-HBc positivity with AOR 1.8(1.4-2.4) and 1.4(1.0-1.9) respectively.Other risk factors as gender,history of blood transfusion,diabetes mellitus,frequent injections,tattooing,previous surgery,hospitalization,Bilharziasis or positive family history of HBV or HCV infections were not found to be associated with positive anti-HBc antibodies.Among anti-HBc positive blood donors,age below thirty was the most significant risk factor for prediction of HBV-DNA positivity with AOR 3.8(1.8-7.9).According to HBV-DNA concentration,positive samples were divided in two groups;group one with HBV-DNA ≥ 200 IU/mL(n = 27) and group two with HBV-DNA < 200 IU/mL(n = 26).No significant difference was detected between both groups as regards mean age,gender,liver enzymes or HBV markers.Serological profiles of all followed up blood recipients showed that,all were negative for the studied HBV markers.Also,HBV DNA was not detected among studied recipients,none developed post-transfusion hepatitis(PTH) and the clinical outcome was good.CONCLUSION:OBI is prevalent among blood donors.Nucleic acid amplification/HBV anti core screening should be considered for high risk recipients to eliminate risk of unsafe blood donation. | Zeinab N Said Manal H El Sayed Iman I Salama Enas K Aboel-Magd Magda H Mahmoud Maged El Setouhy Faten Mouftah Manal B Azzab Heidi Goubran Amal Bassili Gamal E Esmat | 2013 | World Journal of Hepatology2013，5，2： | 4 |
| 2 | Effectiveness of hepatitis B virus vaccination program in Egypt:Multicenter national project显示文摘AIM:To assess the effectiveness of hepatitis B virus(HBV) vaccination program among fully vaccinated children.METHODS:A national community based crosssectional study was carried out in 6 governorates representing Egypt. A total of 3600 children aged from 9 mo to 16 years who were fully vaccinated with HBV vaccine during infancy were recruited. Face to face interviews were carried out and sera were evaluated for hepatitis B surface antigen(HBsA g),anti-HBV core antibodies(total) and quantitative detection of hepatitis B surface antibody using enzyme linked immunoassays techniques. Samples positive to HBs Ag/anti-HBV core antibodies were subjected to quantitative HBV-DNA detection by real time polymerase chain reaction with 3.8 IU/L detection limit. RESULTS:Sero-protection was detected among 2059 children(57.2%) with geometric mean titers 75.4 ± 3.6 IU/L compared to 3.1 ± 2.1 IU/L among nonseroprotected children. Multivariate logistic analysis revealed that older age and female gender were the significant predicting variables for having non seroprotective level,with adjusted odds ratio 3.3,9.1and 14.2 among children aged 5 to < 10,10 to < 15 and ≥ 15 years respectively compared to those < 5 years and 1.1 among girls compared to boys with P < 0.01. HBs Ag was positive in 0.11% and breakthrough infection was 0.36% and 0.39% depending on positivity of anti-HBc and DNA detection respectively. The prevalence of HBV infection was significantly higher among children aged ≥ 7 years(0.59%) compared to 0.07% among younger children with odds ratio equal to 8.4(95%CI:1.1-64.2) and P < 0.01.The prevalence was higher among girls(0.48%) than boys(0.29%) with P > 0.05. C ON C LU S I ON :T he E gy pt ian c ompuls or y H B V vaccination program provides adequate protection. Occult HBV infection exists among apparently healthy vaccinated children. Adherence to infection control measures is mandatory. | Iman I Salama Samia M Sami Zeinab Nabil Ahmed Said Manal H El-Sayed Lobna A El Etreby Thanaa M Rabah Dalia M Elmosalami Amany T Abdel Hamid Somaia I Salama Aida M Abdel Mohsen Hanaa M Emam Safaa M Elserougy Amal I Hassanain Naglaa F Abd Alhalim Fatma A Shaaban Samia A Hemeda Nihad A Ibrahim Ammal M Metwally | 2015 | World Journal of Hepatology2015，7，22： | 2 |
| 3 | A review of the $100 proteins in cancer显示文摘 | Salama I Malone PS Mihaimeed F | 2008 | Eur J Surg Oncol2008，34，4： | 1 |
| 4 | Envelope tracking techniques for flicker mitigation and voltage regulation 显示文摘 | Marei M I EI-Saadany E F Salama M M A | 2004 | IEEE Trans on Power Delivery2004，19，4： | 1 |
| 5 | Needle aspiration cylol ogy of sebaceous carcinoma显示文摘 | Hood I C Qizilbash A H Salama S S | 1984 | Acta Cytol1984，28，： | 1 |
| 6 | Maskless pattern transfer using 355 nm laser 显示文摘 | S R I Gabran R R Mansour M M A Salama | 2012 | Optics and Lasers in Engineering2012，50，5： | 1 |
| 7 | Relationship between fetuin-A and systemic lupus erythematosus as a predictor marker for atherosclerosis显示文摘 | Mosa O F Mohamad I H Salama M M | 2012 | Am Med J2012，3，： | 1 |
| 8 | Hepatitis C virus infected in French hemodialysis units: Amulti-center study 显示文摘 | Salama G Rostaing I Sandres K | 2006 | J Med Virol2006，61，： | 1 |
| 9 | A review of the S100 proteins in cancer显示文摘 | Salama I Malone PS Mihaimeed F | 2008 | Eur J Surg Oncol2008，34，4： | 1 |
| 10 | A review of the S100 proteins in cancer显示文摘 | Salama I Malone PS Mihaimeed F | 2008 | Eur J Surg Oncol2008，34，4： | 1 |
| 11 | A review of the S100 proteins in cancer显示文摘 | Salama I Malone PS Mihaimeed F | | 0，，04： | 1 |
| 12 | Hepatitis C rirus infection in French hemodialysis units:A multi-center study显示文摘 | Salama G Rostaing I Sandres K | 2000 | J Med Virol2000，61，： | 1 |
| 13 | A review of the S100 proteins in cancer 显示文摘 | Salama I Malone PS Mihaimee DF | 2008 | Eur J Surg Onco12008，34，4： | 1 |
| 14 | Laparoscopic esophagogastric devascularization in bleeding varices显示文摘 | Hemly A Abdelkader Salama I Schwaitzberg SD | 2003 | Surg Endose2003，17，10： | 1 |
| 15 | A novel control algorithm for the DG interface to mitigate power quality problems显示文摘 | Marei M I EI-saadany E F Salama M M A | 2004 | IEEE Transactions on Power Delivery2004，19，3： | 1 |
| 16 | Ionotropically crosslinked p H-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs显示文摘 | SHERBINY I M SALAMA A SARHAN A A | 2011 | Drug Dev Ind Pharm2011，37，2： | 1 |
| 17 | A novel control algorithm for the DG interface to mitigate power quality problems显示文摘 | Marei Mostafa I EI-Saadany Ehab F Salama Magdy M A | 2004 | IEEE Trans on Power Delivery2004，19，3： | 1 |
| 18 | A review of the S100 proteins in cancer显示文摘 | Salama I Malone PS Mihaimeed F | 2008 | Eur JSurgOnc2008，34，： | 1 |
| 19 | Synthesis of some 3-(benzimidazol-2-ylmethyl) thiazolidinone derivatives as potential antimicrobial agents显示文摘 | RIDA S M SALAMA H M LABOUTA I M | 1986 | Pharmazie1986，40，10： | 1 |
| 20 | A review of the S100 proteins in cancer 显示文摘 | Salama I Malone PS Mihaimeed F | 2008 | Eur J Surg Oncol2008，34，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员